Juno Therapeutics
Seattle, US · Founded 2013 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
HP
Howard PienDirector
HB
Hal BarronDirector
HB
Hans BishopExecutive Officer, Director, Promoter
BJ
Bernard J. CassidyExecutive Officer
RV
Rupert VesseyDirector
RA
Robert AzelbyExecutive Officer
RK
Richard KlausnerDirector, Promoter
AE
Anthony EvninDirector
MA
Mary Agnes WilderotterDirector
TD
Thomas DanielDirector
SA
Sunil AgarwalExecutive Officer
RN
Robert NelsenDirector, Promoter
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$31.1MraisedOct 2017 · 1 investors · BiotechnologyRule 506(c)
▶$31.1MraisedOct 2017 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Mary Agnes WilderotterDirector
- Hal BarronDirector
- Richard KlausnerDirector, Promoter
- Anthony EvninDirector
- Robert NelsenDirector, Promoter
- Sunil AgarwalExecutive Officer
- Steven HarrExecutive Officer
- Robert AzelbyExecutive Officer
- Thomas DanielDirector
- Howard PienDirector
- Hans BishopExecutive Officer, Director, Promoter
- Bernard J. CassidyExecutive Officer
- Rupert VesseyDirector
- Jay FlatleyDirector
- Offering amount
- $31.1M
- Amount sold
- $31.1M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06c
▶$898.5MraisedJun 2017 · 2 investors · BiotechnologyRule 506(c)
▶$898.5MraisedJun 2017 · 2 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Howard PienDirector
- Hal BarronDirector
- Hans BishopExecutive Officer, Director, Promoter
- Bernard J. CassidyExecutive Officer
- Rupert VesseyDirector
- Robert AzelbyExecutive Officer
- Richard KlausnerDirector, Promoter
- Anthony EvninDirector
- Mary Agnes WilderotterDirector
- Thomas DanielDirector
- Robert NelsenDirector, Promoter
- Sunil AgarwalExecutive Officer
- Jay FlatleyDirector
- Steven HarrExecutive Officer
- Amount sold
- $898.5M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.